Literature DB >> 3510750

Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.

H H Schmeiser, B L Pool, M Wiessler.   

Abstract

The rat liver 9000 g supernatant mediated metabolism of the carcinogenic aristolochic acid, which consists of aristolochic acid I (AAI) and aristolochic acid II (AAII), was investigated. Under anaerobic conditions the major metabolites were the corresponding aristolactams for both AAI and AAII. In contrast under aerobic conditions AAII was not detectably metabolized and the only metabolite found for AAI was the O-demethylated derivative aristolochic acid Ia (AAIa). The metabolites were identified by their u.v., mass and n.m.r. spectra and by comparison with reference standards. The mutagenic activities of the three metabolites were determined in Salmonella typhimurium strains TA1537 and TA 100. The aristolactams were mutagenic in both strains when a metabolizing system was present. These results indicate that AAI or AAII and their aristolactams exert their effect via a common reactive intermediate, probably the corresponding hydroxylamine. AAIa was only very weakly mutagenic and this metabolite may therefore not be regarded as a major mutagenic metabolite of AAI. These findings suggest that the acids are preferentially metabolized by two totally different pathways in vitro, namely an oxidative pathway for AAI and a reductive pathway for AAII.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510750     DOI: 10.1093/carcin/7.1.59

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.

Authors:  Wan Chan; Yufang Zheng; Zongwei Cai
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-05       Impact factor: 3.109

Review 2.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Acute toxicity of aristolochic acid in rodents.

Authors:  U Mengs
Journal:  Arch Toxicol       Date:  1987-02       Impact factor: 5.153

4.  Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.

Authors:  Thomas A Rosenquist; Heidi J Einolf; Kathleen G Dickman; Lai Wang; Amanda Smith; Arthur P Grollman
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

5.  Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology.

Authors:  U Mengs; C D Stotzem
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

Review 6.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

7.  beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.

Authors:  Ying Xiao; Xiang Xue; Yuan-feng Wu; Guo-zheng Xin; Yong Qian; Tian-pei Xie; Li-kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

8.  Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.

Authors:  Shinya Shibutani; Radha R Bonala; Thomas Rosenquist; Robert Rieger; Naomi Suzuki; Francis Johnson; Frederick Miller; Arthur P Grollman
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

9.  DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.

Authors:  Nan Mei; Volker M Arlt; David H Phillips; Robert H Heflich; Tao Chen
Journal:  Mutat Res       Date:  2006-09-28       Impact factor: 2.433

10.  Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.

Authors:  Tao Chen; Lei Guo; Lu Zhang; Leming Shi; Hong Fang; Yongming Sun; James C Fuscoe; Nan Mei
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.